SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-17-168585
Filing Date
2017-05-12
Accepted
2017-05-12 16:06:49
Documents
47
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d394336d10q.htm 10-Q 626830
2 EX-31.1 d394336dex311.htm EX-31.1 8239
3 EX-31.2 d394336dex312.htm EX-31.2 8197
4 EX-32.1 d394336dex321.htm EX-32.1 2980
5 EX-32.2 d394336dex322.htm EX-32.2 2932
  Complete submission text file 0001193125-17-168585.txt   2384037

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ceru-20170331.xml EX-101.INS 250720
7 XBRL TAXONOMY EXTENSION SCHEMA ceru-20170331.xsd EX-101.SCH 28144
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ceru-20170331_cal.xml EX-101.CAL 41646
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ceru-20170331_def.xml EX-101.DEF 96999
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ceru-20170331_lab.xml EX-101.LAB 273191
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ceru-20170331_pre.xml EX-101.PRE 186437
Mailing Address 35 GATEHOUSE DRIVE WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE WALTHAM MA 02451 781-996-4300
Cerulean Pharma Inc. (Filer) CIK: 0001401914 (see all company filings)

IRS No.: 204139823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36395 | Film No.: 17838597
SIC: 2834 Pharmaceutical Preparations